Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
Haruki Uojima(National Center for Global Health and Medicine), Masashi Mizokami(National Institute of Advanced Industrial Science and Technology), Keisuke Hino(Yamaguchi University), Nobuharu Tamaki(The Japanese Society of Gastroenterological Surgery), Hidenori Toyoda(Ogaki Municipal Hospital), Keisuke Amano(Kurume University), Miyako Murakawa(Tokyo Medical and Dental University), Takeji Umemura(Shinshu University), Masaya Sugiyama(National Center for Global Health and Medicine), Satoru Joshita(Shinshu University), Chika Kusano(Kitasato University), Hiroshi Yatsuhashi(Nagasaki Medical Center), Hiroko Iijima(Hyogo University), Norihiro Ishii(Gunma University), Kazumasa Sakamoto(Aichi Medical University), Kiyoaki Ito(Aichi Medical University), Takashi Nishimura(Hyogo University), Sohji Nishina(Kawasaki Medical School), Yasuhiro Asahina(Tokyo Medical and Dental University), Masayuki Kurosaki(Musashino Red Cross Hospital), Akinobu Taketomi(Hokkaido University), Takanori Suzuki(Nagoya City University), Takumi Kawaguchi(Kurume University), Kentaro Matsuura(Nagoya City University), Masayoshi Kage(Junshin Gakuen University), Ken Shirabe(Gunma University), Kazumi Yamasaki(Nagasaki Medical Center), Hisashi Hidaka(Kitasato University)
Cited by 23
Related Papers
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
|American Journal Of Pathology|2004|536
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
|Hepatology|2001|418
A Case–Control Study for Clinical and Molecular Biological Differences Between Hepatitis B Viruses of Genotypes B and C
|Hepatology|2001|396
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346